The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| MGRX | -70.78% | N/A | N/A | -99% |
| S&P | +16.49% | +84.25% | +12.99% | +71% |
Mangoceuticals, Inc. engages in developing, marketing, and selling men’s wellness products and services via a telemedicine platform. The company was founded on October 7, 2021 and is headquartered in Dallas, TX.
No news articles found for Mangoceuticals.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $84.25K | -36.8% |
| Gross Profit | -$250.57K | -403.1% |
| Gross Margin | -297.43% | -359.4% |
| Market Cap | $23.07M | 205.3% |
| Market Cap / Employee | $7.69M | 0.0% |
| Employees | 3 | 0.0% |
| Net Income | -$7,618.78K | -281.0% |
| EBITDA | -$7,241.46K | -322.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $481.28K | 551.2% |
| Inventory | 0 | -100.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.00K | -100.0% |
| Short Term Debt | $112.17K | -56.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -125.56% | -13.5% |
| Return On Invested Capital | -329.48% | 90.6% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$1,241.26K | -6.5% |
| Operating Free Cash Flow | -$1,241.26K | -6.5% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.38 | 0.42 | 0.54 | 1.20 | 116.14% |
| Price to Sales | 12.75 | 17.52 | 29.41 | 54.05 | 472.46% |
| Price to Tangible Book Value | -5.32 | -46.34 | -8.49 | -18.99 | -104.05% |
| Enterprise Value to EBITDA | -4.82 | -1.96 | -3.16 | -3.43 | -19.65% |
| Return on Equity | -109.7% | -115.9% | -82.8% | -135.0% | 8.52% |
| Total Debt | $214.96K | $47.71K | $630.12K | $112.17K | -58.30% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
